KOD: financial statements from SEC — TradeAlmanac

KOD

Kodiak Sciences Inc: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31 Mar 2026	30 Sept 2025	30 Jun 2025	31 Mar 2025	30 Sept 2024	30 Jun 2024
Research and development	49M	50M	43M	44M	32M	33M
Selling, general and administrative	11M	12M	13M	15M	15M	15M
Operating expenses	60M	62M	56M	59M	47M	48M
Operating income	−60M	−62M	−56M	−59M	−47M	−48M
Interest expense	—	—	—	—	0	0
Net income	−58M	−61M	−54M	−57M	−44M	−45M
Earnings per share	−0.94	−1.16	−1.03	−1.09	−0.84	−0.86
Earnings per share, diluted	−0.94	−1.16	−1.03	−1.09	−0.84	−0.86
Weighted average shares	62M	53M	53M	53M	53M	53M
Weighted average shares, diluted	62M	53M	53M	53M	53M	53M

Balance sheet

Metric	31 Mar 2026	31 Dec 2025	30 Sept 2025	30 Jun 2025	31 Mar 2025	31 Dec 2024	30 Sept 2024	30 Jun 2024
Cash and equivalents	170M	210M	72M	104M	139M	168M	198M	219M
Current assets	175M	215M	76M

Cash flow

Metric	31 Mar 2026	31 Mar 2025
Operating cash flow	−40M	−29M
Depreciation and amortisation	4M	5M
Share-based compensation	12M	16M
Capital expenditure	942,000	270,000
Investing cash flow	−942,000	−270,000
Financing cash flow	619,000

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator